Sign Up Today and Learn More About CytoVale Stock
Invest in or calculate the value of your shares in CytoVale or other pre-IPO companies through EquityZen's platform.
CytoVale Stock (CYTV)
CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.
About CytoVale Stock
Founded
2013
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
CytoVale Press Mentions
Stay in the know about the latest news on CytoVale
System and method for determining an immune activation state
patents • May 04, 2025
ICU-Level Care Not Definitive Indicator for Sepsis, New Study Shows
prnewswire • Apr 22, 2025
Global Sepsis Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends
einpresswire • Mar 30, 2025
Appointments and advancements for March 18, 2025
bioworld • Mar 19, 2025
Microfluidic Devices Market Forecast Report 2025-2032: Microfluidic Chips & Sensors Lead Global Market Growth, Projected to Hit $54.61 Billion by 2032
globenewswire • Mar 05, 2025
CytoVale Management
Leadership team at CytoVale
Co-Founder, CEO
Ajay Shah
Co-founder and Board Member
Dino Di Carlo
Join now and verify your accreditation status to gain access to:
- CytoVale Current Valuation
- CytoVale Stock Price
- CytoVale Management
- Available deals in CytoVale and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- CytoVale Cap Table and Funding History by Share Class and Liquidity Preferences
- CytoVale Revenue and Financials
- CytoVale Highlights
- CytoVale Business Model
- CytoVale Risk Factors
- CytoVale Research Report from SACRA Research
Trading CytoVale Stock
How to invest in CytoVale stock?
Accredited investors can buy pre-IPO stock in companies like CytoVale through EquityZen funds. These investments are made available by existing CytoVale shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CytoVale stock?
Shareholders can sell their CytoVale stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
